Results
|
|
4601.
|
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England. [electronic resource] by
- Lee, D
- Amadi, A
- Sabater, J
- Ellis, J
- Johnson, H
- Kotapati, S
- McNamara, S
- Walker, A
- Cooper, M
- Patterson, K
- Roskell, N
- Meng, Y
Publication details: PharmacoEconomics - open 03 2019
In:
PharmacoEconomics - open vol. 3
Availability: No items available.
|
|
|
4602.
|
Biochemical changes in knee articular cartilage of novice half-marathon runners. [electronic resource] by
- Qiu, Leiyu
- Perez, Jose
- Emerson, Christopher
- Barrera, Carlos M
- Zhong, Jianping
- Nham, Fong
- Jose, Jean
- Lesniak, Bryson P
- Kaplan, Lee D
- Baraga, Michael G
Producer: 20200504
In:
The Journal of international medical research vol. 47
Availability: No items available.
|
|
|
4603.
|
|
|
|
4604.
|
|
|
|
4605.
|
|
|
|
4606.
|
Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesity. [electronic resource] by
- Isaac, M
- Slassi, A
- O'Brien, A
- Edwards, L
- MacLean, N
- Bueschkens, D
- Lee, D K
- McCallum, K
- De Lannoy, I
- Demchyshyn, L
- Kamboj, R
Producer: 20001115
In:
Bioorganic & medicinal chemistry letters vol. 10
Availability: No items available.
|
|
|
4607.
|
|
|
|
4608.
|
|
|
|
4609.
|
|
|
|
4610.
|
|
|
|
4611.
|
|
|
|
4612.
|
|
|
|
4613.
|
Rates of p16 (MTS1) mutations in primary tumors with 9p loss. [electronic resource] by
- Cairns, P
- Mao, L
- Merlo, A
- Lee, D J
- Schwab, D
- Eby, Y
- Tokino, K
- van der Riet, P
- Blaugrund, J E
- Sidransky, D
Producer: 19940802
In:
Science (New York, N.Y.) vol. 265
Availability: No items available.
|
|
|
4614.
|
|
|
|
4615.
|
|
|
|
4616.
|
|
|
|
4617.
|
|
|
|
4618.
|
|
|
|
4619.
|
|
|
|
4620.
|
|